AM281 is a selective CB1 receptor antagonist with an IC50 of 9.91 nM. AM281 inhibits CB2 receptor with an IC50 of 13000 nM。
Application:
AM281 has been used as a cannabinoid 1 receptor antagonist: to study its effects on memory deficit following naloxone-precipitated morphine withdrawal in mice to study the role of CB1 receptor system in modulating acetaldehyde-induced effects in rats during the extinction-, relapse-, and conflict-experiments to study its effect on scopolamine-induced memory deficit using object recognition paradigm to block synthetic cannabinoid (HU210)-induced analgesia in the ventrolateral orbital cortex (VLO) to evaluate the effect of CB1 receptors on the VLO modulation of pain
规格
别名
1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-吗啉-1H-吡唑-3-甲酰胺
英文别名
AM 281 | 1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4-morpholinyl-1H-pyrazole-3-carboxamide
规格或纯度
Moligand™, ≥98%
英文名称
AM281
生化机理
与大麻素受体拮抗剂 SR 141716A 类似物相比,AM281 的亲脂性较低。AM281 可通过抑制小鼠的大麻素受体来防止吗啡戒断后的记忆缺失。
强效、选择性 CB1 大麻受体拮抗剂/逆激动剂